 BRIDGEWATER, N.J., May 13, 2021 PRNewswire -- Insmed Incorporated Nasdaq: INSM announced today the closing of the previously announced registered underwritten public offering the Equity Offering of 11,500,000 shares of its common stock the Shares, including 1,500,000 Shares issued pursuant to the exercise in full of the underwriters option to purchase additional Shares, at a price to the public of 25.00 per share before deducting underwriting discounts and commissions, and the previously announced registered underwritten public offering the Notes Offering of 575 million aggregate principal amount of its 0.75 convertible senior notes due 2028 the Notes, including 75 million aggregate principal amount of Notes purchased pursuant to the exercise in full of the underwriters option to purchase additional Notes, solely to cover over-allotments. 